The goal of this presentation is to enhance the reproductive health care of patients with intersex traits through improved understanding of applied reproductive ethics in this field and in adoption of innovations in both the medical and surgical care of these patients. The presentation was recorded at Intersex Traits (Differences in Sex Development); Clinical and ethical considerations in care across the lifespan, on Oct. 25-26, 2021.
Director of Reproductive Bioethics
Center for Bioethics, Harvard Medical School
The goal of this presentation is to enhance learners’ understanding of the reproductive ethics surrounding genital, gonadal and reproductive anatomy and medical interventions, and how this informs the care of patients with intersex traits as well as the laws and policies around intersex patients and their care. The presentation was recorded at Intersex Traits (Differences in Sex Development); Clinical and ethical considerations in care across the lifespan, on Oct. 25-26, 2021.
At the conclusion of this educational program, learners will be able to:
- Discuss the current legal rules that apply or should apply to the treatment of patients with intersex traits (differences of sex development).
- Analyze current treatment practices of patients with intersex traits in the context of reproductive ethics, adolescent autonomy, and historical events regarding reproductive rights.
- To encourage engagement in ethical and legal topics affecting intersex patients.
In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:
Louise P. King, MD, JD: NoneJulie A. Greenberg, JD: None